Algert Global’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.79M Buy
36,993
+26,330
+247% +$5.47M 0.1% 318
2026
Q1
$2.25M Buy
+10,663
New +$2.3M 0.03% 686
2024
Q4
Sell
-9,124
Closed -$1.01M 1181
2024
Q3
$1.01M Buy
+9,124
New +$954K 0.03% 746
2024
Q2
Sell
-2,780
Closed -$311K 1500
2024
Q1
$311K Sell
2,780
-3,783
-58% -$408K 0.01% 887
2023
Q4
$662K Buy
6,563
+540
+9% +$53.6K 0.03% 731
2023
Q3
$523K Sell
6,023
-12,700
-68% -$1.15M 0.02% 730
2023
Q2
$1.77M Buy
18,723
+2,600
+16% +$220K 0.08% 427
2023
Q1
$1.22M Buy
+16,123
New +$1.22M 0.06% 563
2017
Q1
Sell
-28,019
Closed -$2.02M 320
2016
Q4
$2.02M Buy
28,019
+10,753
+62% +$777K 0.58% 56
2016
Q3
$1.34M Sell
17,266
-11,099
-39% -$897K 0.39% 82
2016
Q2
$2.21M Sell
28,365
-28,841
-50% -$2.3M 0.9% 4
2016
Q1
$4.69M Buy
57,206
+39,596
+225% +$3.22M 1.76% 1
2015
Q4
$1.57M Sell
17,610
-16,900
-49% -$1.44M 0.73% 23
2015
Q3
$2.65M Buy
34,510
+9,980
+41% +$834K 1.47% 2
2015
Q2
$2.05M Buy
24,530
+11,040
+82% +$975K 1.13% 4
2015
Q1
$1.22M Buy
+13,490
New +$1.16M 0.68% 26

Other funds holding CAH

Algert Global's CAH Position: Q2 2026 in Review

Algert Global increased its Cardinal Health (CAH) stake by 247% in Q2 2026, buying an estimated $5.47M and bringing the position to 36,993 shares worth $8.79M. The position accounts for 0.1% of the portfolio, ranked #318.

Algert Global first reported a position in CAH in Q1 2015 and has held it in 16 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Algert Global held 36,993 shares of Cardinal Health worth $8.79M as of Q2 2026.
  • Algert Global bought 26,330 Cardinal Health shares in Q2 2026, an estimated $5.47M.
  • Cardinal Health made up 0.1% of Algert Global's portfolio in Q2 2026, its #318 holding.
  • Algert Global first reported a position in Cardinal Health in Q1 2015 and has held it in 16 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.